(1S,2R,4S,6R,7S,1'S,2'R,4'S,6'R,7'S)-4,4'-Oxybis(1,10,10-trimethyl-3-oxatricyclo[5.2.1.0~2,6~]decane)(CAS: 108031-79-4)

This compound must comply with the Globally Harmonized System (GHS) of Classification and Labelling of Chemicals for hazardous properties. Under REACH regulations, it requires a safety data sheet (SDS) and registration if produced or imported in the European Union. In the United States, the FDA and EPA may have specific requirements for its handling and disposal, particularly if it is used in pharmaceutical or environmental applications.

There are several alternatives depending on the specific synthesis needs. Common analogs include other 1,4-dioxane derivatives. Isomers or structural analogs can also provide similar functionalities. For instance, 1,3-dioxane or other cyclic ethers could be used as substitutes in various organic synthesis processes.

Market trends indicate increasing focus on this compound in pharmaceutical and cosmetics industries due to its unique chemical structure and properties. Research is also exploring its potential in green chemistry applications. However, due to its potential hazards, there is a growing interest in safer alternatives and better environmental practices.

Waste containing this compound should be collected in appropriate containers and stored separately. Incineration should be conducted in a licensed facility, and professional waste disposal services should be utilized to ensure compliance with environmental regulations. Proper safety measures, including personal protective equipment (PPE), should be followed to prevent exposure during handling and disposal.